Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Ceftriaxone treatment failure in cephalosporin-susceptible Escherichia coli bacteraemia.

International journal of antimicrobial agents - 1 Mar 2013

Papanicolas Lito E, Bell Jan M, Weldhagen Gerhard F, Bastian Ivan

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Bacterial Agents
Share to Bacteremia
Share to Ceftriaxone
Share to DNA, Bacterial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Escherichia coli

Share to Escherichia coli Infections

Share to Microbial Sensitivity Tests

Share to Treatment Failure

Source

Identifiers

PMID: 23312600
DOI: 10.1016/j.ijantimicag.2012.11.008

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Ceftriaxone treatment failure in cephalosporin-susceptible Escherichia coli bacteraemia.PMID 23312600Read ↗

Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory.Semantic proximity Read ↗

Azithromycin treatment failure in community-acquired pneumonia caused by Streptococcus pneumoniae resistant to macrolides by a 23S rRNA mutation.Semantic proximity Read ↗

Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance.Semantic proximity Read ↗

Clinical-Use-Associated Decrease in Susceptibility of Vancomycin-Resistant Enterococcus faecium to Linezolid: a Comparison with Quinupristin-DalfopristinSemantic proximity Read ↗

Cefiderocol for the Treatment of Infections by VIM-Type-Producing Gram-Negative BacteriaSemantic proximity Read ↗

Real-world multicentre study of cefiderocol treatment of immunocompromised patients with infections caused by multidrug-resistant Gram-negative bacteria: CEFI-IDSemantic proximity Read ↗

Imipenem Resistance: A Clarion Call to Antibiotic StewardshipSemantic proximity Read ↗

Cefiderocol: An Overview of Its in-vitro and in-vivo Activity and Underlying Resistant MechanismsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.